Phytotherapy in diabetes: a review of plant
DOI:
https://doi.org/10.12775/JEHS.2021.11.09.002Keywords
phytotherapy, diabetes, hyperglycemia, hypoglycemic effect, medicinal plantsAbstract
More than 200 species of plants possess antidiabetic properties which were evaluated mostly by screening tests without digging far for the exact mode of action. Searching among the different literature resources and various database, this article provides a comprehensive review on the available antidiabetic plants that have been approved by pharmacological and clinical evaluations, and which their mechanism(s) of action is assured.
References
http://www.who.int/diabetes/en/
Cyganek K. Indywidualizacja postępowania w otyłości. Algorytm leczenia. Przew Lek 2003, 55-61
WHO traditional medicine strategy: 2014-2023.
Phytotherapy in diabetes: Review on potential mechanistic perspectives, 5(2), 176-197
The place of Morus alba in the contemporary pharmacotherapy for type II diabetes. Aleksandra Gnalicka, Anna Jabłecka, 6, 196-201, s.198
Diabetes mellitus and phytotherapy in Turkey. Hulya Parildar, Rustu Serter, Erdem Yesilada; 1116-1120, s. 1118-1119
. The histopathologic effects of Morus alba leaf extract on the pancreas of diabetic rat. Mohammadi J, Naik PR, 211-216, s. 212-213
Bioactive compounds in white mulberry (Morus alba L.) and their therapeutic activity. Joanna Grześkowiak, Małgorzata Łochyńska, 18(1), 31-35, s. 33
Znaczenie substancji aktywnych pochodzenia roślinnego w cukrzycy. Katarzyna Walkiewicz, Anna Nasiek-Palka, Monika Gętek, Małgorzata Muc-Wierzgoń, Teresa Kokot, Katarzyna Klakla, Ewa Nowakowska-Zajdel, 17(1), 49-54, s. 51-52
Cukrzyca i wspomaganie jej leczenia środkami pochodzenia roślinnego. Małgorzata Rzepa, 1-20, s. 14
Medicinal plants in type 2 diabetes mellitus. Małgorzata Kania, Natalia Derebecka, 11 (2), 76-84
Ginger and garlic – herbal materials that lower cholesterol and glucose. Małgorzata Kania-Dobrowolska, Justyna Baraniak, Aleksandra Górska, Marlena Wolek, Anna Bogacz, 169-176, s.172-173
Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics. Olmos PR, Hodgson MI, Maiz A i wsp. 320-333, s.325-329
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 © The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 918
Number of citations: 0